RA

Rapport Therapeutics

NASDAQ: RAPP

Incorporated in Delaware · 2 known investors

rapportrx.com ↗

Rapport is a biopharmaceutical company developing novel therapeutics. The company is led by a team with extensive experience in drug discovery, clinical development, and commercialization across neuroscience and rare disease indications.

Founders & leadership

AC

Abe CeesayPresident

CG

Cheryl Gault

DS

Dr. Sevigny

D

David

T

Troy

S

Swamy

K

Kathy

Investors · 2

AR

ARCH Venture PartnersChicago · $50K – $250M

SO

Sofinnova VenturesMenlo Park · $100K – $15M